Advanced Metal-Based Nano-Drug Delivery Systems for Antimicrobial Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 1
Special Issue Editor
Interests: nanosystems; magnetic NPs; MRI; diagnosis; cancer therapy.
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are excited to announce this Special Issue of Pharmaceutics, titled “Advanced Metal-Based Nano-Drug Delivery Systems for Antimicrobial Therapy”. This Special Issue aims to gather the latest contributions on the design and synthesis of nanosystems based on nanoparticles, micelles, or hydrogels as attractive and versatile platforms for drug delivery and antimicrobial applications.
In this Special Issue, we seek to address one of the major global challenges that medicine will face in the upcoming decades, i.e., antimicrobial resistance (AMR). We believe that therapies based on the combination of nanosystems and metals offer an innovative and versatile approach to combating AMR. This strategy is attracting great interest due to its uniquely sized nanomaterials with suitable properties and the promising antimicrobial activity of metals, such as Ag, Au, Pt, Ru, and Cu.
Therefore, this Special Issue is open for submission of original research articles and reviews that include, but are not limited to, the following topics: the development of drug delivery nanosystems, metal-based nanomaterials, metal-based drugs, controlled drug release, and antimicrobial activities of antibacterial agents.
We look forward to receiving your contributions.
Dr. Manuel Pernia Leal
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanosystems
- micelles
- liposomes
- nanoparticles
- metal-based drugs
- drug delivery
- antimicrobial therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
